IVACAFTOR | N207925 | VERTEX PHARMACEUTICALS INC
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
Vertex Pharmaceuticals Incorporated v. Lupin Limited et al 8 patentsANDA 217431ivacaftor | D. Del. | 2026-01-23 | Active | — |
Vertex Pharmaceuticals Incorporated v. Lupin Limited et al 7 patentsANDA 217431ivacaftor | D. Del. | 2025-04-11 | Active | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
| Patent # | Expiration | PED | Drug Substance | Drug Product | Use Code | Delist |
|---|---|---|---|---|---|---|
| 7495103 | May 20, 2027PED: Nov 20, 2027 | PED | Yes | Yes | — | — |
| 8324242 | Aug 5, 2027PED: Feb 5, 2028 | PED | — | — | — | |
| 8354427 | Jul 6, 2026PED: Jan 6, 2027 | PED | — | — | — | |
| 8410274 | Dec 28, 2026PED: Jun 28, 2027 | PED | — | Yes | — | — |
| 8754224 | Dec 28, 2026PED: Jun 28, 2027 | PED | Yes | Yes | — | — |
| 8883206 | Feb 27, 2033PED: Aug 27, 2033 | PED | — | Yes | — | — |
| 9670163 | Dec 28, 2026PED: Jun 28, 2027 | PED | — | Yes | — | |
| 10272046 | Feb 27, 2033PED: Aug 27, 2033 | PED | — | Yes | — | |
| 10646481 | Aug 13, 2029PED: Feb 13, 2030 | PED | — | Yes | — | — |
| 11147770 | Feb 27, 2033PED: Aug 27, 2033 | PED | — | Yes | — | |
| 11564916 | Aug 13, 2029PED: Feb 13, 2030 | PED | — | — | — | |
| 11752106 | Feb 27, 2033PED: Aug 27, 2033 | PED | — | Yes | — | |
| 12214083 | Feb 27, 2033PED: Aug 27, 2033 | PED | — | Yes | — | |
| 12458635 | Aug 13, 2029PED: Feb 13, 2030 | PED | — | Yes | — |
| Code | Date | Status |
|---|---|---|
| M-14 | May 22, 2028 | Active |
| ODE-236 | Apr 29, 2026 | Expired |
| ODE-338 | Dec 21, 2027 | Active |
| PED | Oct 29, 2026 | < 1 year |